Commonwealth Equity Services LLC Increases Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Commonwealth Equity Services LLC lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 49.7% in the 4th quarter, HoldingsChannel reports. The firm owned 245,476 shares of the company’s stock after buying an additional 81,552 shares during the quarter. Commonwealth Equity Services LLC’s holdings in GE HealthCare Technologies were worth $19,191,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. D1 Capital Partners L.P. purchased a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $268,159,000. Van ECK Associates Corp lifted its position in GE HealthCare Technologies by 107.3% during the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company’s stock valued at $378,520,000 after buying an additional 2,506,417 shares during the period. State Street Corp boosted its holdings in shares of GE HealthCare Technologies by 7.8% during the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company’s stock valued at $1,747,101,000 after buying an additional 1,347,114 shares in the last quarter. Massachusetts Financial Services Co. MA purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth about $93,713,000. Finally, Jennison Associates LLC increased its stake in shares of GE HealthCare Technologies by 124.5% in the 4th quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock worth $133,659,000 after acquiring an additional 948,017 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Up 0.6 %

GEHC opened at $81.97 on Monday. The stock has a market capitalization of $37.48 billion, a price-to-earnings ratio of 18.93, a PEG ratio of 3.19 and a beta of 1.13. The firm has a 50 day moving average price of $87.26 and a 200-day moving average price of $86.13. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price objective for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Citigroup increased their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average target price of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.